Page last updated: 2024-10-28

hydrochlorothiazide and Lymphangiomyomatosis

hydrochlorothiazide has been researched along with Lymphangiomyomatosis in 1 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frank, H1
Weiss, W1

Other Studies

1 other study available for hydrochlorothiazide and Lymphangiomyomatosis

ArticleYear
[A rare cause of edema: sporadic lymphangioleiomyomatosis].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:38

    Topics: Antibiotics, Antineoplastic; Biopsy; Diuretics; Drinking; Female; Humans; Hydrochlorothiazide; Lung

2013